ID
17378
Description
Olmesartan Medoxomil in Hypertension and Renal Impairment; ODM derived from: https://clinicaltrials.gov/show/NCT00151827
Link
https://clinicaltrials.gov/show/NCT00151827
Keywords
Versions (1)
- 9/10/16 9/10/16 -
Uploaded on
September 10, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Essential Hypertension NCT00151827
Eligibility Essential Hypertension NCT00151827
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Malignant Hypertension | Sitting blood pressure
Data type
boolean
Alias
- UMLS CUI [1]
- C0020540
- UMLS CUI [2]
- C0580946
Description
Heart failure Severe | Kidney Disease Severe
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0018801
- UMLS CUI [1,2]
- C0205082
- UMLS CUI [2,1]
- C0022658
- UMLS CUI [2,2]
- C0205082
Description
Myocardial Infarction | Cerebrovascular accident | Transient Ischemic Attack
Data type
boolean
Alias
- UMLS CUI [1]
- C0027051
- UMLS CUI [2]
- C0038454
- UMLS CUI [3]
- C0007787
Description
Gastrointestinal Disease Significant Evidence of | Respiration Disorder | Hematological Disease | Metabolic Disease | Immune System Disease | Disease Interferes with Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0017178
- UMLS CUI [1,2]
- C0750502
- UMLS CUI [1,3]
- C0332120
- UMLS CUI [2]
- C0035204
- UMLS CUI [3]
- C0018939
- UMLS CUI [4]
- C0025517
- UMLS CUI [5]
- C0021053
- UMLS CUI [6,1]
- C0012634
- UMLS CUI [6,2]
- C0521102
- UMLS CUI [6,3]
- C2348568
Description
Hypersensitivity Angiotensin II receptor antagonist | Medical contraindication Angiotensin II receptor antagonist | Hypersensitivity Angiotensin-Converting Enzyme Inhibitors | Medical contraindication Angiotensin-Converting Enzyme Inhibitors | Hypersensitivity Allergens Cross Reactive
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0521942
- UMLS CUI [2,1]
- C1301624
- UMLS CUI [2,2]
- C0521942
- UMLS CUI [3,1]
- C0020517
- UMLS CUI [3,2]
- C0003015
- UMLS CUI [4,1]
- C1301624
- UMLS CUI [4,2]
- C0003015
- UMLS CUI [5,1]
- C0020517
- UMLS CUI [5,2]
- C0002092
- UMLS CUI [5,3]
- C0010357
Description
Illicit Drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0086190
Description
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Inadequate
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3,1]
- C3831118
- UMLS CUI [3,2]
- C0700589
- UMLS CUI [3,3]
- C0205412
Description
Substance Use Disorders
Data type
boolean
Alias
- UMLS CUI [1]
- C0038586
Similar models
Eligibility Essential Hypertension NCT00151827
- StudyEvent: Eligibility
C0444504 (UMLS CUI [1,2])
C2945599 (UMLS CUI [1,2])
C1565489 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C0373595 (UMLS CUI [3])
C0580946 (UMLS CUI [2])
C0205082 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0750502 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
C0035204 (UMLS CUI [2])
C0018939 (UMLS CUI [3])
C0025517 (UMLS CUI [4])
C0021053 (UMLS CUI [5])
C0012634 (UMLS CUI [6,1])
C0521102 (UMLS CUI [6,2])
C2348568 (UMLS CUI [6,3])
C0521942 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0003015 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0003015 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0002092 (UMLS CUI [5,2])
C0010357 (UMLS CUI [5,3])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])